3 SEHK Growth Companies With Insider Ownership Expecting Up To 71% Earnings Growth

In This Article:

As global markets experience varied economic shifts, with notable declines in Hong Kong's Hang Seng Index, investors are keenly observing growth opportunities within the region. In this environment, companies with high insider ownership and significant earnings growth potential stand out as potentially strong contenders for those seeking to navigate market fluctuations effectively.

Top 10 Growth Companies With High Insider Ownership In Hong Kong

Name

Insider Ownership

Earnings Growth

Laopu Gold (SEHK:6181)

36.4%

33.2%

Akeso (SEHK:9926)

20.5%

53%

Fenbi (SEHK:2469)

33.1%

22.4%

RemeGen (SEHK:9995)

15.9%

52.2%

Zylox-Tonbridge Medical Technology (SEHK:2190)

18.8%

69.8%

Pacific Textiles Holdings (SEHK:1382)

11.2%

37.7%

DPC Dash (SEHK:1405)

38.1%

104.2%

Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)

13.9%

109.2%

Beijing Airdoc Technology (SEHK:2251)

29.4%

93.4%

Zhejiang Leapmotor Technology (SEHK:9863)

15%

69.7%

Click here to see the full list of 47 stocks from our Fast Growing SEHK Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Beauty Farm Medical and Health Industry

Simply Wall St Growth Rating: ★★★★★☆

Overview: Beauty Farm Medical and Health Industry Inc. operates in the beauty and health sector, providing medical cosmetology services, with a market cap of HK$4.02 billion.

Operations: The company generates revenue from various segments, including CN¥851.81 million from Aesthetic Medical Services, CN¥125.69 million from Subhealth Medical Services, CN¥1.14 billion from Beauty and Wellness Services - Direct Stores, and CN¥131.48 million from Beauty and Wellness Services - Franchisee and Others.

Insider Ownership: 33.9%

Earnings Growth Forecast: 20.2% p.a.

Beauty Farm Medical and Health Industry shows promising growth potential, with earnings expected to grow significantly at 20.2% annually, outpacing the Hong Kong market. Recent half-year results reported sales of CNY 1.14 billion and net income of CNY 115.42 million, reflecting steady growth. Despite no recent insider trading activity, high insider ownership aligns interests with shareholders. The appointment of Mr. Hu Tenghe as a non-executive director strengthens the board with his extensive capital markets experience.

SEHK:2373 Earnings and Revenue Growth as at Oct 2024
SEHK:2373 Earnings and Revenue Growth as at Oct 2024

Jiangxi Rimag Group

Simply Wall St Growth Rating: ★★★★★☆